Cargando…
Management of Melanoma Families
In this review we have aimed to focus on the clinical management of familial melanoma patients and their relatives. Along this line three major topics will be discussed: (1) management/screening of familial melanoma families: what is advised and what is the evidence thereof; (2) variability of famil...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3835091/ https://www.ncbi.nlm.nih.gov/pubmed/24281082 http://dx.doi.org/10.3390/cancers2020549 |
_version_ | 1782292098577334272 |
---|---|
author | Bergman, Wilma Gruis, Nelleke A. |
author_facet | Bergman, Wilma Gruis, Nelleke A. |
author_sort | Bergman, Wilma |
collection | PubMed |
description | In this review we have aimed to focus on the clinical management of familial melanoma patients and their relatives. Along this line three major topics will be discussed: (1) management/screening of familial melanoma families: what is advised and what is the evidence thereof; (2) variability of families worldwide with regard to clinical phenotype, including cancer spectrum and likelihood of finding germline mutations and (3) background information for clinicians on the molecular biology of familial melanoma and recent developments in this field. |
format | Online Article Text |
id | pubmed-3835091 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | Molecular Diversity Preservation International (MDPI) |
record_format | MEDLINE/PubMed |
spelling | pubmed-38350912013-11-21 Management of Melanoma Families Bergman, Wilma Gruis, Nelleke A. Cancers (Basel) Review In this review we have aimed to focus on the clinical management of familial melanoma patients and their relatives. Along this line three major topics will be discussed: (1) management/screening of familial melanoma families: what is advised and what is the evidence thereof; (2) variability of families worldwide with regard to clinical phenotype, including cancer spectrum and likelihood of finding germline mutations and (3) background information for clinicians on the molecular biology of familial melanoma and recent developments in this field. Molecular Diversity Preservation International (MDPI) 2010-04-16 /pmc/articles/PMC3835091/ /pubmed/24281082 http://dx.doi.org/10.3390/cancers2020549 Text en © 2010 by the authors; licensee Molecular Diversity Preservation International, Basel, Switzerland. http://creativecommons.org/licenses/by/3.0/ This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/). |
spellingShingle | Review Bergman, Wilma Gruis, Nelleke A. Management of Melanoma Families |
title | Management of Melanoma Families |
title_full | Management of Melanoma Families |
title_fullStr | Management of Melanoma Families |
title_full_unstemmed | Management of Melanoma Families |
title_short | Management of Melanoma Families |
title_sort | management of melanoma families |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3835091/ https://www.ncbi.nlm.nih.gov/pubmed/24281082 http://dx.doi.org/10.3390/cancers2020549 |
work_keys_str_mv | AT bergmanwilma managementofmelanomafamilies AT gruisnellekea managementofmelanomafamilies |